These findings indicate that insulin may play an inhibitory role in regulating ZAG expression, positioning ZAG not only as a key player in the pathogenesis of obesity and metabolic syndrome but also as a potential therapeutic target [12,18]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.